Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP 129Xe MRI for CLAD Evaluation
NCT05550662Phase 2Terminated
- Sponsor
- SickKids
- Start
- Feb 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in chronic lung allograft dysfunction (CLAD), sponsored by SickKids. Started Feb 2024; status: terminated.
02
Drugs
hyperpolarized xenon gas
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT05550662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550662.